Ultimovacs: Video interview with CEO Carlos de Sousa

Research Interview



Redeye interviews Ultimovacs’ CEO Carlos de Sousa. We talk about the company’s recent top-line data readout for NIPU and its implications for UV1 going forward.


Christian Binder

Sign up for free to continue

Already a member?

Sign in

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.